Join us Thursday 4/24 at 2pm Central Time, as we focus on the valuation range for Ford (F). Register here. HIDE

Array BioPharma (ARRY)

Add to Watchlists
Create an Alert
3.80 +0.02  +0.53% NASDAQ Apr 23, 8:00PM BATS Real time Currency in USD
View Full Chart
ARRY Price Chart
View All Events

ARRY Events

Date Type Description
Feb 04 Misc Q2 2014 Array BioPharma Inc. Earnings Conference Call
Feb 04 Earnings Q2 2014 Array BioPharma Inc. Earnings Results. Estimate: -0.17.
Oct 31 Misc Array Biopharma Inc. Q1 2014 Earnings Conference Call
Oct 31 Earnings Array Biopharma to Report Financial Results for the First Quarter of Fiscal 2014 on October 31, 2013. Estimate: -0.18.
Oct 23 Misc AGM Event for Array Biopharma Inc.
Aug 08 Misc Q4 2013 Array Biopharma Inc. Earnings Conference Call
Aug 07 Earnings Array Biopharma to Report Financial Results for the Fourth Quarter and Full Year of Fiscal 2013 on August 7, 2013. Estimate: -0.13.
May 07 Misc Q3 2013 Array Biopharma Inc. Earnings Conference Call
May 06 Earnings Array Biopharma to Report Financial Results for the Third Quarter of Fiscal 2013 on May 6, 2013. Estimate: -0.15.
View All Performance Charts

ARRY Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Array BioPharma is down 36.16% over the last year vs S&P 500 Total Return up 22.59%, Celldex Therapeutics up 13.07%, and Oncothyreon up 9.71%.

Get Quote for

PDF Report for ARRY

Download Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.

Download ARRY Pro Report PDF
Advertisement

Portfolio Strategies Featuring ARRY

Did Array BioPharma make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

ARRY Profile

  • Sector: Healthcare
  • Industry: Biotechnology
  • Headquarters Country: United States
  • Headquarters State/Province: Colorado
  • Incorporation Country: United States
  • Incorporation State/Province: Colorado
  • Est. Current Fiscal Quarter End: June 30, 2014
  • Est. Current Fiscal Year End: June 30, 2014
  • Last Fiscal Quarter End: N/A
  • Last Fiscal Year End: N/A
  • NAICS: Pharmaceutical Preparation Manufacturing
  • NAICS Code: 325412
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Industry Code: 3254
  • NAICS Sector: Manufacturing
  • NAICS Sector Code: 32

Array BioPharma, Inc., is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer and inflammatory diseases.

Recent Quotes

Symbol Price Chg Chg % Market Cap
ARRY 3.80 +0.02 +0.53% 477.36M
Create Watchlist from Quotes
Advertisement

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

required
required
required
required
required
Get Started Now
document.write('');

{{root.upsell.info.feature_headline}}.
Upgrade to {{root.upsell.info.tier_name}}. Start Your YCharts Membership. Start your {{root.upsell.info.tier_name}} Membership

{{root.upsell.info.feature_description}}

{{root.upsell.info.is_upgrade ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{root.upsell.info.tier_name}} Member? Sign in here.